MICROB-PREDICT
@microb-predict.bsky.social
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825694.
Website: https://microb-predict.eu/
Website: https://microb-predict.eu/
Pinned
Feel free to join and "follow all" in our starter pack ☺️: go.bsky.app/4cMqxsU
Feel free to join and "follow all" in our starter pack ☺️: go.bsky.app/4cMqxsU
February 11, 2026 at 7:50 PM
Feel free to join and "follow all" in our starter pack ☺️: go.bsky.app/4cMqxsU
🥳 Congratulations, David Tornai et al. from Maria Papp's team at the University of Debrecen! The paper has been viewed more than 625 times since its publication in Dec 2025 & is currently amongst the top-downloaded articles!
#SerumVillin #GutBarrier #ACLF
📰 onlinelibrary.wiley.com/doi/10.1111/...
#SerumVillin #GutBarrier #ACLF
📰 onlinelibrary.wiley.com/doi/10.1111/...
February 11, 2026 at 2:33 PM
🥳 Congratulations, David Tornai et al. from Maria Papp's team at the University of Debrecen! The paper has been viewed more than 625 times since its publication in Dec 2025 & is currently amongst the top-downloaded articles!
#SerumVillin #GutBarrier #ACLF
📰 onlinelibrary.wiley.com/doi/10.1111/...
#SerumVillin #GutBarrier #ACLF
📰 onlinelibrary.wiley.com/doi/10.1111/...
🩺🧪🦠 Thank you, team MICROB-PREDICT, for a strong and successful 15th #SteeringCommittee Meeting. Two intense days with excellent science and great discussions - held in a time of shared grief as we remember #PeerBork from #EMBL 🖤, our esteemed colleague and mentor🕯️. We move forward with momentum! 💪
January 27, 2026 at 5:04 PM
🩺🧪🦠 Thank you, team MICROB-PREDICT, for a strong and successful 15th #SteeringCommittee Meeting. Two intense days with excellent science and great discussions - held in a time of shared grief as we remember #PeerBork from #EMBL 🖤, our esteemed colleague and mentor🕯️. We move forward with momentum! 💪
Prof. Peer Bork, EMBL Interim Director General, died on 16 January 2026. A remarkable scientist and leader, he played a pivotal role in MICROB-PREDICT, inspiring colleagues & mentees alike - leaving a lasting scientific legacy. Our heartfelt condolences to his family. Thank you for everything, Peer!
January 19, 2026 at 8:38 PM
Prof. Peer Bork, EMBL Interim Director General, died on 16 January 2026. A remarkable scientist and leader, he played a pivotal role in MICROB-PREDICT, inspiring colleagues & mentees alike - leaving a lasting scientific legacy. Our heartfelt condolences to his family. Thank you for everything, Peer!
Save the date! We look forward to our upcoming steering committee (SC) meeting from 26-27 January 2026. We’ll hear about the results in all work packages and align the consortium's efforts for the next steps in our cross-disciplinary collaboration! @easlnews.bsky.social @horizoneu.bsky.social
January 15, 2026 at 4:48 PM
Save the date! We look forward to our upcoming steering committee (SC) meeting from 26-27 January 2026. We’ll hear about the results in all work packages and align the consortium's efforts for the next steps in our cross-disciplinary collaboration! @easlnews.bsky.social @horizoneu.bsky.social
www.cccb.org/es/actividad...
In 2026, the Universitat de Barcelona will collaborate again with the Centre de Cultura Contemporània de Barcelona (CCCB) to talk about "bodies, data, and the market - Reflections from bioethics" - don't miss it!
📅 26 February and 5, 12, 19 and 26 March 2026
In 2026, the Universitat de Barcelona will collaborate again with the Centre de Cultura Contemporània de Barcelona (CCCB) to talk about "bodies, data, and the market - Reflections from bioethics" - don't miss it!
📅 26 February and 5, 12, 19 and 26 March 2026
December 22, 2025 at 3:07 PM
www.cccb.org/es/actividad...
In 2026, the Universitat de Barcelona will collaborate again with the Centre de Cultura Contemporània de Barcelona (CCCB) to talk about "bodies, data, and the market - Reflections from bioethics" - don't miss it!
📅 26 February and 5, 12, 19 and 26 March 2026
In 2026, the Universitat de Barcelona will collaborate again with the Centre de Cultura Contemporània de Barcelona (CCCB) to talk about "bodies, data, and the market - Reflections from bioethics" - don't miss it!
📅 26 February and 5, 12, 19 and 26 March 2026
🫖 Snuggle in with a cup of tea and a blanket over the holidays to read this year's MICROB-PREDICT publications - Wishing everyone relaxing winter holidays and a wonderful start into the New Year! ❄️
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
December 22, 2025 at 2:38 PM
🫖 Snuggle in with a cup of tea and a blanket over the holidays to read this year's MICROB-PREDICT publications - Wishing everyone relaxing winter holidays and a wonderful start into the New Year! ❄️
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
📖 microb-predict.eu/for-scientis...
@medblab.bsky.social
@easlnews.bsky.social
@ec.europa.eu
Reposted by MICROB-PREDICT
As the year draws to a close, we are wrapping up 2025 with gratitude, momentum, and a spirit of community at concentris. ✨
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
New calls & Project highlights from concentris
Calls opening soon *** EU Clusters in cancer prevention & environmental health, *** New QSPainRelief Database *** Important Policy Recommendations for people with Down syndrome from GO-DS21 *** Pediat...
mailchi.mp
December 19, 2025 at 9:11 AM
As the year draws to a close, we are wrapping up 2025 with gratitude, momentum, and a spirit of community at concentris. ✨
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
💡Curious about what’s next in 2026, and how these developments could support your work?
Read our latest #newsletter:
🔗 mailchi.mp/concentris/n...
👏 New study from Dávid Tornai and colleagues 🎉: Serum #Villin1 is a promising non-invasive marker of #GutBarrier damage in #cirrhosis and #ACLF.
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
Serum Villin‐1—A Novel Marker of Gut Barrier Damage in Acutely Decompensated Cirrhosis: A Cohort Study and Validation
Serum villin-1 is a non-invasive indicator of gut barrier damage and short-term mortality in acutely decompensated cirrhosis. Incorporating villin-1 assessment into risk stratification methods improv...
doi.org
December 8, 2025 at 1:39 PM
👏 New study from Dávid Tornai and colleagues 🎉: Serum #Villin1 is a promising non-invasive marker of #GutBarrier damage in #cirrhosis and #ACLF.
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
📽️ Now online 🎧: lnkd.in/dJuMmsc4
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
November 27, 2025 at 3:20 PM
📽️ Now online 🎧: lnkd.in/dJuMmsc4
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
Watch or listen to the newest EASL Studio Episode on “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance” from Wednesday, 26 Nov 2026.
#rifaximin #HepaticEncephalopathy #AntimicrobialResistance #cirrhosis #ACLF
On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance”
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
November 24, 2025 at 12:05 PM
On Wednesday, 26 Nov, at 6 pm CET, EASL Studio hosts a new episode titled “Rifaximin for Hepatic Encephalopathy: Balancing Benefits and Risks in the Era of Antimicrobial Resistance”
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
The episode will be broadcast live on EASL.eu and can be accessed here:
📹 easl.eu/easl-studio-...
Don't miss it ☺️
🎉 Our new #mirobiome paper in #JHEP is out! We found distinct gut #virome shifts in #ACLF - from virulent to temperate #phages - with Lactococcus A + Enterococcus B phages linked to infections & higher 90-day mortality
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
October 24, 2025 at 11:33 AM
🎉 Our new #mirobiome paper in #JHEP is out! We found distinct gut #virome shifts in #ACLF - from virulent to temperate #phages - with Lactococcus A + Enterococcus B phages linked to infections & higher 90-day mortality
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
👉 Read more: www.sciencedirect.com/science/arti...
📽️Video: youtu.be/0YF6qToBQUM
🌍 The MICROB-PREDICT team met in Münster, Germany from 1–2 October for its 14th Steering Committee Meeting!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
October 24, 2025 at 11:18 AM
🌍 The MICROB-PREDICT team met in Münster, Germany from 1–2 October for its 14th Steering Committee Meeting!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
👉 Team leaders discussed results from 20 new papers about late-stage #LiverDisease #cirrhosis #biomarkers and IPR topics as the project nears its final phase.
The finish line is in sight!
🚨 New #LiverFailure insights 🚨
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
September 23, 2025 at 12:40 PM
🚨 New #LiverFailure insights 🚨
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
In patients with #cirrhosis + acute #decompensation, secretory #IgA strongly correlates with #gut-barrier failure and is a powerful predictor of 90-day mortality in acute-on-chronic #LiverFailure #ACLF
👉 Watch on YouTube: youtu.be/KapUqG7AFFk
#Biomarkers #GutBarrier
👏 ALB-TRIAL hits 50% enrollment 🎉
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
August 27, 2025 at 12:41 PM
👏 ALB-TRIAL hits 50% enrollment 🎉
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
Half of the planned 240 patients have now been recruited across 14 centres in 7 countries - great progress for the MICROB-PREDICT project!
Huge thanks to all site teams - Onward to full enrollment & better treatment for #cirrhosis patients with #ascites!
#albumin
Reposted by MICROB-PREDICT
Join this exciting event!
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
May 28, 2025 at 8:21 PM
Join this exciting event!
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
Don't miss our #OpenInnovation event, uniting experts in #DrugDevelopment, #bioinformatics, and #hepatology. Connect with researchers, industry professionals, and investors to share insights & explore collaboration opportunities!
🚀 Register now: inevent.uk/en/Crowdheli...
Reposted by MICROB-PREDICT
🧪 SAT-209 – #EASL2025
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
May 10, 2025 at 12:22 PM
🧪 SAT-209 – #EASL2025
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
MNK6106 vs. rifaximin to treat #HepaticEncephalopathy - new Phase 2a data from Prof. @rajivjalan.bsky.social (UCL) explores safety, PK & ammonia-lowering potential. HE treatment innovation in motion! #Cirrhosis
Reposted by MICROB-PREDICT
🧠 SAT-210 – #EASL2025
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
May 10, 2025 at 12:23 PM
🧠 SAT-210 – #EASL2025
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
New tool alert!
The #mHEST scale brings clarity to grading hepatic #encephalopathy in trials & clinics. A big step for #cirrhosis care. Kudos to Prof. @rajivjalan.bsky.social & his team!
#LiverHealth #HE #ClinicalResearch
🔬 Improving the prognostic performance of the #MELD score is a challenge that Nikolaj Torp (Odense University Hospital) took on, comparing the original score with MELD 3.0 in 777 patients with an acute #decompensation of #cirrhosis
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
May 10, 2025 at 2:00 PM
🔬 Improving the prognostic performance of the #MELD score is a challenge that Nikolaj Torp (Odense University Hospital) took on, comparing the original score with MELD 3.0 in 777 patients with an acute #decompensation of #cirrhosis
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
#POSTER SAT-196-YI 👏
📅 Presented at #EASLCongress | #EASL2025
Reposted by MICROB-PREDICT
✨ #PosterTour today at #EASLCongress 2025:
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
May 10, 2025 at 12:04 PM
✨ #PosterTour today at #EASLCongress 2025:
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
All our 3 Horizon2020 #LiverResearch projects in 1 session!
Topic: #Cirrhosis & #PortalHypertension
Chair: Maria Papp
💡 Big moments:
#AMMON-OHE model for post-#TIPS #encephalopathy (Rajiv Jalan)
#Terlipressin response in AKI-HRS w/ CKD (Frank Uschner)
One last time #LIVE from the #EASLStudio: Tot Ziens Amsterdam, Hola Barcelona! 👋
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
May 10, 2025 at 10:01 AM
One last time #LIVE from the #EASLStudio: Tot Ziens Amsterdam, Hola Barcelona! 👋
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
As #EASL2025 draws to a close, Debbie Shawcross and Aleksander Krag reflect on the highlights from Amsterdam and set the stage for #EASL2026 in Barcelona.
Thank you for an inspiring #EASLCongress - see you next year!
🧪 Mads Israelsen (Odense Universitetshospital – Svendborg Sygehus) leads together with Alberto Zanetto the YI #Workshop on How to prepare a #Clinical #Practice #Guideline in Hepatology, offering valuable insights for young investigators.
📅 Presented at the #EASLCongress | #EASL2025
📅 Presented at the #EASLCongress | #EASL2025
May 10, 2025 at 9:17 AM
🧪 Mads Israelsen (Odense Universitetshospital – Svendborg Sygehus) leads together with Alberto Zanetto the YI #Workshop on How to prepare a #Clinical #Practice #Guideline in Hepatology, offering valuable insights for young investigators.
📅 Presented at the #EASLCongress | #EASL2025
📅 Presented at the #EASLCongress | #EASL2025
One last time at #EASL2025: Wim Laleman (KUL) hosts the EASL/CIRSE Skills Learning Centre session on #Liver #Haemodynamics, providing hands-on learning in liver disease management.
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
🔬 EASL/CIRSE Skills Learning Centre: Liver Haemodynamics
Join Wim Laleman (KUL) for an in-depth session on Liver Haemodynamics
📅 Presented at the #EASLCongress | #EASL2025
🕙 10:00 – 11:00
Also available at 12:30, 14:00, and 16:15!
@easlnews.bsky.social @cirsesociety.bsky.social
Join Wim Laleman (KUL) for an in-depth session on Liver Haemodynamics
📅 Presented at the #EASLCongress | #EASL2025
🕙 10:00 – 11:00
Also available at 12:30, 14:00, and 16:15!
@easlnews.bsky.social @cirsesociety.bsky.social
May 10, 2025 at 7:48 AM
One last time at #EASL2025: Wim Laleman (KUL) hosts the EASL/CIRSE Skills Learning Centre session on #Liver #Haemodynamics, providing hands-on learning in liver disease management.
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
🕙 10:15 – 11:15, Skills Learning Centre 2
@easlnews.bsky.social @cirsesociety.bsky.social
Live from the #EASLCongress: Debbie Shawcross (KCL) presents on Rebooting immunity: Harnessing FMT to revive innate defences in #cirrhosis as part of the Symposium “Microbiome and liver health: Unveiling new therapeutic pathways” 🦠🧫
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
May 10, 2025 at 7:29 AM
Live from the #EASLCongress: Debbie Shawcross (KCL) presents on Rebooting immunity: Harnessing FMT to revive innate defences in #cirrhosis as part of the Symposium “Microbiome and liver health: Unveiling new therapeutic pathways” 🦠🧫
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
#EASL2025 @easlnews.bsky.social
@kingscollegelondon.bsky.social
Join us at the Industry Room: Evolving concepts in MASLD, ALD & MetALD at #EASLCongress
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD
May 10, 2025 at 7:27 AM
Join us at the Industry Room: Evolving concepts in MASLD, ALD & MetALD at #EASLCongress
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD
Learn about:
✏️ New terminology & pathophysiology
🔬Non-invasive tools for diagnosis, prognosis & monitoring
🚨 Stay updated on the latest in metabolic & alcohol-related liver disease!
#MASLD #MetALD